Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.73 +0.14 (+1.84%)
At close: Oct 21, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Short term Debt (2022 - 2024)

Updated

Eupraxia Pharmaceuticals (EPRX) reported Short term Debt of $79,418 for the quarter ended Dec 31, 2022.

Analysis

Eupraxia Pharmaceuticals (EPRX) Short term Debt (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Eupraxia Pharmaceuticals 308.46 Mn -133.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -355,582.00
Dec 31, 2023 10.40 Mn
Dec 31, 2022 79,418.00
API Access

Eupraxia Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=EPRX&period=max&api_key=YOUR_API_KEY